S. Selvan

发表

Remedial yoga module remarkably improves symptoms in irritable bowel syndrome patients: A 12-week randomized controlled trial

Vijaya Kavuri, P. Selvan, A. Malamud, 2015 .

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

H. Maecker, S. Hu-Lieskovan, Yingdong Zhao, 2020, Journal for ImmunoTherapy of Cancer.

Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines

S. Selvan, M. Ravindranath, E. Filippone, 2022, Vaccines.

Establishment of stable cell lines for personalized melanoma cell vaccine

S. Selvan, R. Dillman, M. Ravindranath, 2010, Melanoma research.

Expression of insulin‐like growth factor‐1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth

H. Rui, R. Baserga, T. Deangelis, 2014, Pigment cell & melanoma research.

Phase I/II trial of autologous tumor cell line-derived vaccines for recurrent or metastatic sarcomas.

N. Barth, S. Selvan, R. Dillman, 2004, Cancer biotherapy & radiopharmaceuticals.

Application of Varma Kalai (art of vital points) in autism spectrum disorder

S. Selvan, P. Selvan, P. Balamurugen, 2021 .

Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines

T. S. Saravanan, S. Brosman, S. Selvan, 2006, Evidence-based complementary and alternative medicine : eCAM.

Immunogenic gangliosides in human ovarian carcinoma.

T. S. Saravanan, D. Morton, S. Selvan, 2007, Biochemical and biophysical research communications.

Hapten-Induced Contact Hypersensitivity, Autoimmune Reactions, and Tumor Regression: Plausibility of Mediating Antitumor Immunity

S. Selvan, Dan A Erkes, 2014, Journal of immunology research.

“Adherent” versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy

S. Selvan, J. Dowling, 2015, BioMed research international.

Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis

S. Selvan, M. Ravindranath, E. Filippone, 2022, Antibodies.

Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic

S. Selvan, J. Peter, D. Abraham, 2022, Medical Journal Armed Forces India.

Rapid Presumptive Identification of Burkholderia mallei and Burkholderia pseudomallei Clinical Isolates Using a Highly Specific Lateral Flow Assay.

S. Selvan, S. Morse, Shashi K. Sharma, 2022, Health security.

Validation of a Lateral Flow Test for the Presumptive Identification of the Presence of Burkholderia mallei or Burkholderia pseudomallei in Environmental Samples.

S. Selvan, S. Morse, Shashi K. Sharma, 2022, Health security.

Autoimmunity in Reproductive Health and Pregnancy

S. Selvan, J. Tabarkiewicz, N. Cools, 2018, Journal of immunology research.

Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines.

G. Fogel, S. Selvan, R. Dillman, 2011, Cancer biotherapy & radiopharmaceuticals.

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.

N. Barth, S. Selvan, R. Dillman, 2009, Cancer biotherapy & radiopharmaceuticals.

Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.

N. Barth, S. Selvan, R. Dillman, 2004, Cancer biotherapy & radiopharmaceuticals.

Complementary and Integrative Oncology in the Cross-Cultural Region of the Middle East and South Asia

S. Selvan, B. Cassileth, F. Afifi, 2012, Evidence-based complementary and alternative medicine : eCAM.

Protective Effect of Adhatoda vascia Nees Against Radiation-Induced Damage at Cellular, Biochemical and Chromosomal Levels in Swiss Albino Mice

S. Selvan, R. Samarth, Ashok Kumar, 2006, Evidence-based complementary and alternative medicine : eCAM.

The Humoral Theory of Transplantation

F. Claas, S. Ferrone, Junchao Cai, 2017, Journal of immunology research.

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Cell-Mediated Immunity and Vaccines

S. Chattopadhyay, S. Selvan, R. Dalmo, 2014, Journal of immunology research.

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

S. Selvan, Takami Sato, M. Terai, 2011, Immunologic research.

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients

S. Selvan, M. Ravindranath, E. Filippone, 2022, Antibodies.

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Yingdong Zhao, Holden Maecker, Sylvia Janetzki, 2008, Journal of Translational Medicine.

Monitoring response to treatment in melanoma patients: Potential of a serum glycomic marker

S. Selvan, R. Dillman, M. Ravindranath, 2008, International journal of cancer.

Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.

S. Brosman, D. Morton, S. Selvan, 2004, Biochemical and biophysical research communications.

Establishment and characterization of a human primary prostate carcinoma cell line, HH870

N. Rao, S. Selvan, R. Dillman, 2005, The Prostate.

Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients*

S. Selvan, P. Terasaki, M. Ravindranath, 2012, Journal of immunotoxicology.

Editorial Complementary and Integrative Oncology in the Cross-Cultural Regionof theMiddleEastand SouthAsia

S. Selvan, B. Cassileth, F. Afifi, 2012 .

Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine.

S. Selvan, R. Dillman, R. Kim, 2010, Cancer biotherapy & radiopharmaceuticals.

Proteomic profiles by multiplex microsphere suspension array.

Viswanathan V Krishnan, Senthamil R Selvan, Nishanth Parameswaran, 2018, Journal of immunological methods.

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies.

S. Selvan, W. Kelly, J. Dowling, 2016, Current cancer drug targets.

Irritable Bowel Syndrome: Yoga as Remedial Therapy

Vijaya Kavuri, A. Malamud, N. Raghuram, 2015, Evidence-based complementary and alternative medicine : eCAM.

Patient-specific dendritic-cell vaccines for metastatic melanoma.

S. Selvan, R. Dillman, P. Schiltz, 2006, The New England journal of medicine.

Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?

S. Selvan, R. Dillman, S. Nayak, 2005, Cancer biotherapy & radiopharmaceuticals.

Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?

S. Selvan, M. Ravindranath, E. Filippone, 2023, Biomolecules.

Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment

S. Selvan, L. Morales-Buenrostro, M. Ravindranath, 2023, Antibodies.

Hapten-Induced Contact Hypersensitivity, Autoimmune Reactions, and Tumor Regression: Plausibility of Mediating Antitumor Immunity

S. Selvan, Dan A Erkes, 2014, Journal of immunology research.

Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response.

S. Selvan, G. Bertenshaw, Gregory M. Botting, 2021, Cancer biotherapy & radiopharmaceuticals.